Michel Schneeberger

6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial.

J. Wójcik, M. Morice, P. Barragan, 2015, Journal of the American College of Cardiology.

6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel).

J. Wójcik, M. Morice, P. Barragan, 2017, JACC. Cardiovascular interventions.

Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.

P. Barragan, V. Auffret, M. Bedossa, 2016, International journal of cardiology.

Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients non-resistant to aspirin: ITALIC, a randomized multicenter trial

J. Wójcik, M. Morice, P. Barragan, 2014 .

Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients nonresistant to aspirin : ITALIC , a randomized multicenter trial Running title : ITALIC : 6 versus 24 month DAPT

J. Wójcik, M. Morice, P. Barragan, 2014 .